Menstrual function and childbearing potential after fertility-sparing surgery and platinum-based chemotherapy for malignant ovarian germ cell tumours

References

• Kurman RJ, Norris HJ. Malignant germ cell tumors of the ovary. Hum Pathol 1977;8:551–64
   PubMedGoogle Scholar
• Scully RE. Tumors of the ovary, maldeveloped gonads, fallopian tubes and broad ligament. Washington (DC): Armed Forces Institute of Pathology; 1998
   Google Scholar
• Low JJ, Ilancheran A, Ng JS. Malignant ovarian germ-cell tumours. Best Pract Res ClinObstetGynaecol 2012;26:347–55
   Google Scholar
• Talerman A. Germ cell tumors of the ovary. In: Kurman RJ, ed. Blaustein's pathology of the female genital tract, 4th ed. New York: Spring-Verlag, 1994:849–914
   Google Scholar
• Abu-Rustum NR, Aghajanian C. Management of malignant germ cell tumors of the ovary. SeminOncol 1998;25:235–42
   Google Scholar
• Tewari K, Cappuccini F, DiSaia PJ, et al. Malignant germ cell tumors of the ovary. Obstet. Gynecol 2000;95:128–33
   Google Scholar
• Brewer M, Gershenson DM, Herzog CE, et al. Outcome and reproductive function after chemotherapy for ovarian dysgerminoma. J ClinOncol 1999;17:2670–5
   PubMed Web of Science ®Google Scholar
• Low JJ, Perrin LC, Crandon AJ, Hacker NF. Conservative surgery to preserve ovarian function in patients with malignant ovarian germ cell tumors. A review of 74 cases. Cancer 2000;89:391–8
   Google Scholar
• Gershenson DM, Morris M, Cangir A, et al. Treatment of malignant germ cell tumors of the ovary with bleomycin, etoposide and cisplatin. J Clin Oncol 1990;8:715–20
   PubMed Web of Science ®Google Scholar
• Williams S, Blessing JA, Liao SY, et al. Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide, and bleomycin: a trial of the Gynecologic Oncology Group. J Clin Oncol 1994;12:701–6
   PubMedGoogle Scholar
• Edraki B, Schwartz PE. Fertility and reproductive potential of patients with endodermal sinus tumors of the ovary treated conservatively. CMEJ. Gynecol Oncol 1997;2:144–7
   Google Scholar
• Edraki B, Schwartz PE. Fertility after conservative treatment for ovarian immature teratoma. Int J Gynecol Cancer 1997;7:227–32
   Google Scholar
• Perrin LC, Low J, Nicklin JL, et al. Fertility and ovarian function after conservative surgery for germ cell tumours of the ovary. Aust N Z J Obstet Gynaecol 1999;39:243–5
   PubMed Web of Science ®Google Scholar
• El-Lamie IK, Shehata NA, Abou-Loz SK, El-Lamie KI. Conservative surgical management of malignant ovarian germ cell tumors: the experience of the Gynecologic Oncology Unit at Ain Shams University. Eur J Gynaecol Oncol 2000;21:605–9
   PubMed Web of Science ®Google Scholar
• Zanetta G, Bonazzi C, Cantù MG, et al. Survival and reproductive function after treatment of malignant germ cell ovariantumors. J Clin Oncol 2001;19:1015–20
   PubMed Web of Science ®Google Scholar
• Schwartz PE. Surgery of germ cell tumours of the ovary. Forum 2000;10:355–65
   Google Scholar
• Weinberg LE, Lurain JR, Singh DK, Schink JC. Survival and reproductive outcomes in women treated for malignant ovarian germ cell tumors. GynecolOncol 2011;121:285–9
   PubMed Web of Science ®Google Scholar
• Kumar S, Shah JP, Bryant CS, et al. The prevalence and prognostic impact of lymph node metastasis in malignant germ cell tumors of the ovary. GynecolOncol 2008;110:125–32
   PubMed Web of Science ®Google Scholar
• Peccatori F, Bonazzi C, Chiari S, et al. Surgical management of malignant ovarian germ-cell tumors: 10 years' experience of 129 patients. Obstet Gynecol 1995;86:367–72
   PubMed Web of Science ®Google Scholar
• Pectasides D, Pectasides E, Kassanos D. Germcell tumors of the ovary. Cancer Treat Rev 2008;34:427–41
   PubMed Web of Science ®Google Scholar
• Talukdar S, Kumar S, Bhatla N, et al. Neo-adjuvant chemotherapy in the treatment of advanced malignant germ cell tumors of ovary. Gynecol Oncol 2013; S0090-8258(13)01254-7
   Google Scholar
• Mangili G, Scarfone G, Gadducci A, et al. Is adjuvant chemotherapy indicated in stage I pure immature ovarian teratoma (IT)? A multicentre Italian trial in ovarian cancer (MITO-9). Gynecol Oncol 2010;119:48–52
   PubMed Web of Science ®Google Scholar
• Vicus D, Beiner ME, Clarke B, et al. Ovarian immature teratoma: treatment and outcome in a single institutional cohort. Gynecol Oncol 2011;123:50–3
   Google Scholar
• Thomas GM, Dembo AJ, Hacker NF, DePetrillo AD. Current therapy for dysgerminoma of the ovary. Obstet Gynecol 1987;70:268–75
   Google Scholar
• Williams SD, Blessing JA, Hatch KD, Homesley HD. Chemotherapy of advanced dysgerminoma: trials of the Gynecologic Oncology Group. J Clin Oncol 1991;9:1950–5
   Google Scholar
• Culine S, Lhomme C, Kattan J, et al. Cisplatin-based chemotherapy in dysgerminoma of the ovary: thirteen-year experience at the Institut Gustave Roussy. Gynecol Oncol 1995;58:344–8
   PubMed Web of Science ®Google Scholar
• Dimopoulos MA, Papadopoulou M, Andreopoulou E, et al. Favorable outcome of ovarian germ cell malignancies treated with cisplatin or carboplatin-based chemotherapy: a Hellenic Cooperative Oncology Group study. Gynecol Oncol 1998;70:70–4
   Google Scholar
• Baranzelli MC, Bouffet E, Quintana E, et al. Non-seminomatousovariangermcelltumours in children. Eur J Cancer 2000;36:376–83
   Google Scholar
• Casey AC, Bhodauria S, Shapter A, et al. Dysgerminoma: the role of conservative surgery. Gynecol Oncol 1996;63:352–7
   Google Scholar
• A L Husaini H, Soudy H, El DinDarwish A, et al. Pure dysgerminoma of the ovary: a single institutional experience of 65 patients. Med Oncol 2012;29:2944–8
   Google Scholar
• Gershenson DM, Miller AM, Champion VL, et al. Reproductive and sexual function after platinum-based chemotherapy in long-term ovarian germ cell tumor survivors: a Gynecologic Oncology Group Study. J Clin Oncol 2007;25:2792–7
   PubMed Web of Science ®Google Scholar
• Curtin JP, Morrow CP, D' Ablaing G, Schlaerth JB. Malignant germ cell tumors of the ovary: 20-year report of LAC-USC Women's Hospital. Int J Gynecol Cancer 1994;4:29–35
   Google Scholar
• Williams SD, Kauderer J, Burnett AF, et al. Adjuvant therapy of completely resected dysgerminoma with carboplatin and etoposide: a trial of the Gynecologic Oncology Group. Gynecol Oncol 2004;95:496–9
   PubMed Web of Science ®Google Scholar
• Kang H, Kim TJ, Kim WY, et al. Outcome and reproductive function after cumulative high-dose combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for patients with ovarian endodermal sinus tumor. Gynecol Oncol 2008;111:106–10
   PubMed Web of Science ®Google Scholar
• de La Motte Rouge T, Pautier P, Duvillard P, et al. Survival and reproductive function of 52 women treated with surgery and bleomycin, etoposide, cisplatin (BEP) chemotherapy for ovarian yolk sac tumor. Ann Oncol 2008;19:1435–41
   PubMedGoogle Scholar
• Bower M, Fife K, Holden L, et al. Chemotherapy for ovarian germ cell tumours. Eur J Cancer 1996;32A:593–7
   PubMed Web of Science ®Google Scholar
• Ezzat A, Raja M, Bakri Y, et al. Malignant ovarian germ cell tumours – a survival and prognostic analysis. Acta Oncol 1999;38:455–60
   PubMed Web of Science ®Google Scholar
• Kanazawa K, Suzuki T, Sakumoto K. Treatment of malignant ovarian germ cell tumors with preservation of fertility: reproductive performance after persistent remission. Am J Clin Oncol 2000;23:244–8
   Google Scholar
• Vicus D, Beiner ME, Klachook S, et al. Pure dysgerminoma of the ovary 35 years on: a single institutional experience. Gynecol Oncol 2010;117:23–6
   Google Scholar
• Tangir J, Zelterman D, Ma W, Schwartz PE. Reproductive function after conservative surgery and chemotherapy for malignant germ cell tumors of the ovary. Obstet Gynecol 2003;101:251–7
   PubMed Web of Science ®Google Scholar
• Kitajima Y, Endo T, Hayashi T, et al. A successful IVF-pregnancy in a patient who underwent conservative surgery followed by a regimen of cisplatin, vinblastine and peplomycin to treat an advanced ovarian mixed germ cell tumour: a case report. Hum Reprod 2007;22:850–2
   Google Scholar
• Tzortzatos G, Sioutas A, Schedvins K. Successful pregnancy after treatment for ovarian malignant teratoma with growing teratoma syndrome. Fertil Steril 2009;91:936. e1–e3
   Google Scholar